SCHEMBL3323740

SCHEMBL3323740

O=C(Nc1cccnc1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.75
MEN1 O00255 2/20 0.67
USP2 O75604 2/20 0.67
KMT2A Q03164 2/20 0.67
EPHX2 P34913 1/20 0.67
CYP17A1 P05093 2/20 0.61
CYP19A1 P11511 2/20 0.61
HSD11B1 P28845 1/20 0.61
ALDH1A1 P00352 3/20 0.57
KDM4E B2RXH2 2/20 0.57
TP53 P04637 1/20 0.57
HPGD P15428 1/20 0.57
NPSR1 Q6W5P4 2/20 0.55
HSD17B10 Q99714 2/20 0.55
ALOX15 P16050 1/20 0.55
HTT P42858 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
TSHR P16473 2/20 0.54
CNR2 P34972 1/20 0.52
NPC1 O15118 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705995 0.81 P2RX7 (0.71) P2RX7MEN1KMT2AEPHX2HPGD
SCHEMBL13333015 0.76 CYP17A1 (1.00) P2RX7MEN1KMT2ACYP17A1CYP19A1
SCHEMBL1947902 0.76 SMN1; SMN2 (0.66) P2RX7MEN1KMT2AALDH1A1TP53
SCHEMBL13333016 0.74 HSD11B1 (0.77) P2RX7MEN1KMT2ACYP17A1CYP19A1
SCHEMBL3324030 0.74 CYP17A1 (0.72) P2RX7USP2EPHX2CYP17A1CYP19A1
SCHEMBL31552469 0.74 P2RX7 (0.60) P2RX7MEN1KMT2AEPHX2TP53
SCHEMBL25408547 0.74 HTT (0.59) MEN1USP2KMT2AEPHX2ALDH1A1
SCHEMBL31435464 0.74 HTT (0.59) MEN1USP2KMT2AEPHX2ALDH1A1
SCHEMBL1073464 0.73 SMN1; SMN2 (0.65) P2RX7MEN1KMT2AEPHX2HSD11B1
SCHEMBL11741818 0.73 P2RX7 (0.75) P2RX7MEN1KMT2AEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
EP-1861384-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2007-12-05 EP disclosed
WO-2006100502-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS STERIX LIMITED (GB) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors HSD3B1, HSD3B2, HSD11B1 P2RX7 3719/4885MEN1 3474/4885USP2 2756/4885
US-20100120789-A1 Compound NR0B2, NR0B1, NR4A1 P2RX7 991/4885MEN1 2608/4885USP2 4356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.